* Departments of Pediatrics, Hiroshima University School of Medicine,
Child Health, Hiroshima University Graduate School of Education, and
# Cellular and Molecular Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan;
Department of Pediatrics, Mie University School of Medicine, Tsu, Japan;
Department of Developmental Pediatrics, Nagoya University School of Medicine, Japan; and
¶ Department of Pediatrics, Fukui Red-Cross Hospital, Japan
Correspondence: Masao Kobayashi, M.D., Department of Child Health, Hiroshima University Graduate School of Education, 1-1-1 Kagamiyama, Higashi-Hiroshima, Hiroshima, 739-8524 Japan. E-mail: masak{at}hiroshima-u.ac.jp
We examined the expression of granule constituent genes in myeloid progenitor cells during proliferation and differentiation in patients with severe congenital neutropenia (SCN). The heterozygous mutation of the neutrophil elastase gene was identified in two of four patients. The CD34+/granulocyte-colony stimulating factor receptor (G-CSFR)+ cells of SCN patients showed defective responsiveness to G-CSF in serum-deprived culture. The CD34+/G-CSFR+ cells expressed low levels of the granule constituent mRNAs. The transcription levels of primary granule enzyme genes in CD34+/G-CSFR+ cells were gradually enhanced and then decreased when cells were induced toward myeloid lineage with G-CSF in normal subjects. However, the primary up-regulation and the following down-regulation of these enzyme transcriptions were not clearly observed in SCN patients. No differences in expressions of the lactoferrin gene were seen between normal subjects and patients with SCN. We hypothesize that the abnormal regulation of the transcription in primary granule constituents might involve the defective proliferation and differentiation of myeloid cells in patients with SCN.
Key Words: G-CSF • G-CSF receptor • myelopoiesis • neutrophil elastase gene
This article has been cited by other articles:
 |
|
 |
|
  D. S. Grenda, M. Murakami, J. Ghatak, J. Xia, L. A. Boxer, D. Dale, M. C. Dinauer, and D. C. Link Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis Blood, December 15, 2007; 110(13): 4179 - 4187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Matsubara, K. Imai, S. Okada, M. Miki, N. Ishikawa, M. Tsumura, T. Kato, O. Ohara, S. Nonoyama, and M. Kobayashi Severe developmental delay and epilepsy in a Japanese patient with severe congenital neutropenia due to HAX1 deficiency Haematologica, December 1, 2007; 92(12): e123 - e125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Badolato, M. Donini, G. Savoldi, and S. Dusi Response: ELA2 genotype-phenotype correlation to be expected in patients with severe congenital neutropenia Blood, October 1, 2007; 110(7): 2773 - 2774. [Full Text] [PDF]
|
|
|
|
|
|
M. Donini, S. Fontana, G. Savoldi, W. Vermi, L. Tassone, F. Gentili, E. Zenaro, D. Ferrari, L. D. Notarangelo, F. Porta, et al. G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms Blood, June 1, 2007; 109(11): 4716 - 4723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Horwitz, Z. Duan, B. Korkmaz, H.-H. Lee, M. E. Mealiffe, and S. J. Salipante Neutrophil elastase in cyclic and severe congenital neutropenia Blood, March 1, 2007; 109(5): 1817 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bellanne-Chantelot, S. Clauin, T. Leblanc, B. Cassinat, F. Rodrigues-Lima, S. Beaufils, C. Vaury, M. Barkaoui, O. Fenneteau, M. Maier-Redelsperger, et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register Blood, June 1, 2004; 103(11): 4119 - 4125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Fujiwara, F. El Ouriaghli, M. Grube, D. A. Price, K. Rezvani, E. Gostick, G. Sconocchia, J. Melenhorst, N. Hensel, D. C. Douek, et al. Identification and in vitro expansion of CD4+ and CD8+ T cells specific for human neutrophil elastase Blood, April 15, 2004; 103(8): 3076 - 3083. [Abstract] [Full Text] [PDF]
|
|
